The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Sang, surprised you think 2 people coming to the same or similar conclusion strange. All invested in avacta have, at some point, reached a conclusion that it is worth an investment, whether it be long or short term.
However, I didn't make a suggestion, I made the statement which I'll repeat ,"again you've made the case to dump your ISA holding".
Now I'll ask a question. What was the investment criteria that drew you to Avacta & when was that?
Wyndrum, thanks for reply. In the event you are correct & as you are a keen chartist, how do expect the sp to unfold (or indeed unravel) over the next month? A gradual decline, or 'lumpy'? Guess you'll be unloading at least some in the very near future.
From rns 24 Feb
Aiming to bring test to market around end of first quarter this year.
When iso13485 achieved ce mark will be transferred from mologic. Expected end march
Bams - evaluation continues another 2/3 weeks
Think all we can expect is (a lot of) news by the end of the month, not necessarily this week.
Very exciting.
From bsi https://www.bsigroup.com/en-GB/medical-devices/our-services/Medical-Device-Single-Audit-Program/
As you say 5 countries, although Mologic's certificate only mentions 3.